Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
BLBioLife Solutions, Inc. logo

BioLife Solutions, Inc. (BLFS)

NASDAQ Capital Market · Currency in USD
$38.61 ▲ +0.00 (+0.00%)
At close: Oct 5, 4:00 PM ET. Market closed.
$39.00 ▲ +0.39 (+1.01%)
After hours: Oct 5, 7:30 PM ET

Summary

Previous Close
$38.61
Open
$37.16
Day's Range
$37.00 – $38.83
52 Week Range
$17.86 – $39.76
Volume
4,393,546
Avg. Volume
1,108,133
Market Cap
$1.89B
Beta (5Y Monthly)
1.92
PE Ratio (TTM)
37.34
EPS (TTM)
$1.03
Earnings Date
Nov 5, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$31.00

Profile: BioLife Solutions, Inc.

Sector
Healthcare
Industry
Medical - Instruments & Supplies
Full-time employees
155
CEO
Roderick de Greef

BioLife Solutions, Inc. (BLFS) operates as a global provider of specialized bioproduction tools and services, primarily catering to the cell and gene therapy industry. Its market reach extends across the United States, Canada, Europe, the Middle East, Africa, and other international regions. The company's offerings are essential for various stages of biologic-based therapy development, spanning from foundational and applied research to large-scale commercial manufacturing.

Earnings

Next report: Thu, Nov 5, 2026
EPS estimate $0.05 · Revenue est. $29.13M
DateEst.Actual
Aug 6, 2026$0.03$0.91Beat
May 7, 2026$0.01$0.04Beat
Feb 26, 2026-$0.02$0.04Beat
Nov 6, 2025$0.00$0.04Beat
Aug 7, 2025-$0.02-$0.33Miss
May 8, 2025-$0.03$0.04Beat

Analyst view

Consensus price target
$31.00 ▼ -19.7%
Range $31.00 – $31.00
Rating: Buy
Buy 67% · Hold 33% · Sell 0%

Get free alerts on BLFS and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.